At a time when one in two women is likely to suffer from excessive hair loss in their lifetime   [1], the hair care segment is increasingly gaining interest within the global nutricosmetics market. Capitalizing on over 10 years of expertise in skin care, Seppic is now extending its know-how to hair, with promising clinical results.

The maintenance and renewal of healthy hair is directly correlated with its lipid composition. This is why ceramides, known for their involvement in the formation of intracellular lipids, play a key role and act as a barrier protecting the hair cuticle.  

Based on this knowledge, Seppic launched a clinical study on its natural nutraceutical ingredient CERAMOSIDES™, obtained from wheat lipids and rich in phytoceramides.

A gold standard clinical study was carried out on a panel of women of all ages suffering from non-pathological hair loss. In only three months, the results highlighted significant effects on various key hair parameters:

-          a significant growth by 12.5% in hair length vs. placebo

-          a 2-fold increase in the number of hairs in the growth phase: +11,000 (vs. less than 5,000 for the placebo group)

-          a significant reduction by 27% in hair loss vs. placebo

-          a significant improvement in hair resistance to breakage through enhanced hair elasticity

-          a significant reduction of scalp sebum in women with a tendency towards oiliness

This new study thus extends the field of application of CERAMOSIDES™, whose anti-aging and moisturizing efficacy on the skin has already been proven by three clinical studies. CERAMOSIDES™ is vegan, guaranteed with no GMOs, no additives, no preservatives and is gluten-free. It is also certified kosher and is available in organic grade.


Seppic in brief

A subsidiary of Air Liquide Healthcare, Seppic designs, produces and distributes for 80 years a wide range of specialty ingredients for cosmetic, nutraceutical, pharmaceutical, veterinary and industrial products. Seppic employs close to 900 people worldwide, including 110 employees dedicated to innovation who develop effective ingredients with unique characteristics. Present in 100 countries through its subsidiaries and its network of distributors, Seppic aims to help everyone live well, and in good health in a healthy environment.www.seppic.com

Air Liquide Healthcare

AIr Liquide Healthcare supplies medical gases, home healthcare services, medical equipment and specialty ingredients.

In 2022, it served over 15,000 hospitals and clinics and more than 1.9 million patients at home throughout the world. The Group’s Healthcare business reached €3.9 billion in revenues in 2022, with the support of its 16,400 employees.

Zrzut ekranu 2022 01 26 o 12.38.58

Zurück nach oben